Cargando…

Cerebral blood flow in Alzheimer’s disease

BACKGROUND: Alzheimer’s disease (AD) dementia is a consequence of heterogeneous and complex interactions of age-related neurodegeneration and vascular-associated pathologies. Evidence has accumulated that there is increased atherosclerosis/arteriosclerosis of the intracranial arteries in AD and that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roher, Alex E, Debbins, Josef P, Malek-Ahmadi, Michael, Chen, Kewei, Pipe, James G, Maze, Sharmeen, Belden, Christine, Maarouf, Chera L, Thiyyagura, Pradeep, Mo, Hua, Hunter, Jesse M, Kokjohn, Tyler A, Walker, Douglas G, Kruchowsky, Jane C, Belohlavek, Marek, Sabbagh, Marwan N, Beach, Thomas G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481957/ https://www.ncbi.nlm.nih.gov/pubmed/23109807 http://dx.doi.org/10.2147/VHRM.S34874

Ejemplares similares

Morphological and Pathological Evolution of the Brain Microcirculation in Aging and Alzheimer’s Disease
por: Hunter, Jesse M., et al.
Publicado: (2012)

Alzheimer's Disease and Non-Demented High Pathology Control Nonagenarians: Comparing and Contrasting the Biochemistry of Cognitively Successful Aging
por: Maarouf, Chera L., et al.
Publicado: (2011)

Quantitative Appraisal of Ventricular Cerebrospinal Fluid Biomarkers in Neuropathologically Diagnosed Parkinson’s Disease Cases Lacking Alzheimer’s Disease Pathology
por: Maarouf, Chera L., et al.
Publicado: (2013)

Molecular Differences and Similarities Between Alzheimer’s Disease and the 5XFAD Transgenic Mouse Model of Amyloidosis
por: Maarouf, Chera L, et al.
Publicado: (2013)

Bapineuzumab Alters Aβ Composition: Implications for the Amyloid Cascade Hypothesis and Anti-Amyloid Immunotherapy
por: Roher, Alex E., et al.
Publicado: (2013)

The biochemical aftermath of anti-amyloid immunotherapy
por: Maarouf, Chera L, et al.
Publicado: (2010)

Biochemical Assessment of Precuneus and Posterior Cingulate Gyrus in the Context of Brain Aging and Alzheimer’s Disease
por: Maarouf, Chera L., et al.
Publicado: (2014)

Reduced clinical and postmortem measures of cardiac pathology in subjects with advanced Alzheimer's Disease
por: Beach, Thomas G, et al.
Publicado: (2011)

Histopathological and molecular heterogeneity among individuals with dementia associated with Presenilin mutations
por: Maarouf, Chera L, et al.
Publicado: (2008)

Sensitivity to change and prediction of global change for the Alzheimer’s Questionnaire
por: Malek-Ahmadi, Michael, et al.
Publicado: (2015)

Informant-reported cognitive symptoms that predict amnestic mild cognitive impairment
por: Malek-Ahmadi, Michael, et al.
Publicado: (2012)

Visualizing Alzheimer's disease progression in low dimensional manifolds
por: Seo, Kangwon, et al.
Publicado: (2019)

Platelet BACE1 levels as a possible biomarker for Alzheimer’s disease
por: Decourt, Boris, et al.
Publicado: (2013)

The Sun Health Research Institute Brain Donation Program: Description and Eexperience, 1987–2007
por: Beach, Thomas G., et al.
Publicado: (2008)

Essential Tremor in the Elderly and Risk for Dementia
por: Shill, Holly A., et al.
Publicado: (2014)

Impaired hepatic amyloid-beta degradation in Alzheimer’s disease
por: Maarouf, Chera L., et al.
Publicado: (2018)

KIF6 719Arg Carrier Status Association with Homocysteine and C-Reactive Protein in Amnestic Mild Cognitive Impairment and Alzheimer's Disease Patients
por: Malek-Ahmadi, Michael, et al.
Publicado: (2013)

The influence of Apolipoprotein E genotype on regional pathology in Alzheimer’s disease
por: Sabbagh, Marwan N, et al.
Publicado: (2013)

Differences in Cerebrospinal Fluid Biomarkers between Clinically Diagnosed Idiopathic Normal Pressure Hydrocephalus and Alzheimer’s Disease
por: Tsai, Andrew, et al.
Publicado: (2014)

Deactivation of the left dorsolateral prefrontal cortex in Prader-Willi syndrome after meal consumption
por: Reinhardt, Martin, et al.
Publicado: (2016)

Neuropathological comparisons of amnestic and nonamnestic mild cognitive impairment
por: Dugger, Brittany N., et al.
Publicado: (2015)

Converging mediators from immune and trophic pathways to identify Parkinson disease dementia
por: Lue, Lih-Fen, et al.
Publicado: (2016)

Plasma Levels of Aβ42 and Tau Identified Probable Alzheimer’s Dementia: Findings in Two Cohorts
por: Lue, Lih-Fen, et al.
Publicado: (2017)

Improved diagnosis of Parkinson's disease from a detailed olfactory phenotype
por: Gerkin, Richard C., et al.
Publicado: (2017)

Polymorphism of brain derived neurotrophic factor influences β amyloid load in cognitively intact apolipoprotein E ε4 carriers()
por: Adamczuk, Katarzyna, et al.
Publicado: (2013)

The role of sex differences in depression in pathologically defined Alzheimer’s disease
por: Tremblay, Cécilia, et al.
Publicado: (2023)

Gender Differences in Alzheimer Disease: Brain Atrophy, Histopathology Burden, and Cognition
por: Filon, Jessica R., et al.
Publicado: (2016)

Editorial Introduction
por: Sabbagh, Marwan N.
Publicado: (2016)

Editorial Introduction to the Special Issue from the International Symposium on Biomarkers for Alzheimer’s Disease and Related Disorders
por: Sabbagh, Marwan N.
Publicado: (2017)

Taking an Impression Where the Aveolar Ridge Is Soft in Places
por: Belden, G. F.
Publicado: (1904)

Clinical Recommendations for Reducing the Risk of Cognitive Decline
por: Perez, G Adriana, et al.
Publicado: (2021)

Broader Considerations of Higher Doses of Donepezil in the Treatment of Mild, Moderate, and Severe Alzheimer's Disease
por: Berk, Camryn, et al.
Publicado: (2012)

Progressive cholinergic decline in Alzheimer's Disease: consideration for treatment with donepezil 23 mg in patients with moderate to severe symptomatology
por: Sabbagh, Marwan, et al.
Publicado: (2011)

Neurology and Therapy: Looking Back on 2018 and Forward to 2019
por: Sabbagh, Marwan, et al.
Publicado: (2019)

Acknowledgement to Authors, Referees and Readers 2019
por: Sabbagh, Marwan, et al.
Publicado: (2019)

Prevalence of Hippocampal Sclerosis in a Clinicopathologically Characterized Cohort
por: Malek-Ahmadi, Michael, et al.
Publicado: (2013)

Florbetaben for PET Imaging of Beta-Amyloid Plaques in the Brain
por: Richards, Danielle, et al.
Publicado: (2014)

Acknowledgement to Authors, Referees, and Readers
por: Sabbagh, Marwan N., et al.
Publicado: (2018)

Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
por: Sabbagh, Marwan N., et al.
Publicado: (2019)

Open Peer Commentary to “Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE Trials as reported by Biogen December 2019”
por: Sabbagh, Marwan Noel, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vn0j66t94l355uef6jmet935r9